Rosacea Review - Newsletter of the National Rosacea Society

Patients Who Follow Directions Achieve High Rate of Success

Rosacea sufferers who follow their doctor's orders regarding medical therapy and also make appropriate lifestyle modifications achieve a high rate of success in controlling their condition, according to a recent survey of Rosacea Review readers.

In the survey of 520 rosacea patients, 51 percent were under treatment with topical therapy alone and 34 percent were using a combination of both oral and topical antibiotics. Only 11 percent had been prescribed oral antibiotic tablets alone.

Seventy-one percent of the respondents said they used their medication as directed and 22 percent said they usually complied. Of those who followed their doctor's orders, 92 percent said the medical therapy had reduced their rosacea symptoms.

In addition to using medications, 69 percent of the respondents said they had made lifestyle changes to avoid factors that trigger rosacea flare-ups. Of these patients, 84 percent reported that their lifestyle modifications had reduced their rosacea flare-ups.

According to the survey respondents, the most common reasons for not complying with medical therapy were forgetfulness and side effects.




Follow us on Social Media





Contact Us

National Rosacea Society
196 James St.
Barrington, IL 60010

Our Mission

The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace

consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.